The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 222.00
Bid: 221.50
Ask: 222.50
Change: -1.00 (-0.45%)
Spread: 1.00 (0.451%)
Open: 220.00
High: 224.00
Low: 220.00
Prev. Close: 223.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: European large-caps rise on eve of Fed decision

Tue, 19th Mar 2024 16:57

(Alliance News) - Blue-chip stock prices in Europe closed higher on Tuesday, showing little signs of nerves ahead of Wednesday's Federal Reserve decision and UK inflation reading.

A key week for central bank decisions kicked off with a historic hike by the Bank of Japan, though that failed to spur on the yen.

The FTSE 100 index rose 15.75 points, 0.2%, at 7,738.30. The FTSE 250 ended down 53.72 points, 0.3%, at 19,432.81, and the AIM All-Share fell 1.07 points, 0.2%, at 735.56.

The Cboe UK 100 rose 0.2% to 774.76, the Cboe UK 250 fell 0.3% to 16,869.44, and the Cboe Small Companies closed up 0.3% at 14,818.14.

In European equities on Tuesday, the CAC 40 in Paris ended up 0.7%, while the DAX 40 in Frankfurt added 0.3%.

In New York, the Dow Jones Industrial Average was up 0.6% at the time of the closing bell in Europe. The S&P 500 rose 0.2%, though the Nasdaq Composite was fractionally lower.

The pound was quoted at USD1.2719 at the time of the London equities close, a touch lower from USD1.2722 on Monday. The euro stood at USD1.0860, down against USD1.0877.

The US Federal Reserve is expected to once again leave interest rates unmoved on Wednesday, while also dialling back cut expectations in its latest dot-plot.

The US central bank announces its latest interest rate decision at 1800 GMT on Wednesday. A press conference with Chair Jerome Powell follows shortly after. Threatening to hog the spotlight, the latest summary of economic projections will be revealed alongside the decision. The SEP features the dot-plot of interest rate expectations of policymakers.

In December, the chart suggested the Fed will enact three cuts this year.

With the CME FedWatch Tool suggesting a 99% chance the central bank holds in March, a 93% likelihood it does the same in May, and hope of a June cut dwindling, the December plot could be hawkishly re-jigged.

"The US data continue to come in mostly firmer and despite Powell's recent dovish testimony before Congress, most Fed officials remain very cautious about easing too soon. We believe that the current market easing expectations for the Fed still need to adjust. When they do, the dollar should gain further. Last week's inflation data sparked the start of this process and the FOMC decision tomorrow will be key for the continuation of this move," Brown Brothers Harriman analysts commented.

The Bank of England will also be in focus this week, with a UK inflation reading to come on Wednesday, the eve of Threadneedle Street's interest rate decision.

Ebury analyst Matthew Ryan commented: "Data on both UK inflation and wages has surprised to the downside since the last meeting, although both remain far too high for comfort and insufficient to warrant a change in guidance. There will be no Monetary Policy Report or press conference, but the statement will likely stress that policy will remain restrictive, with rates to be kept 'under review'.

"The key for markets will be the voting pattern among committee members. We are pencilling in another unprecedented three-way split, whereby one votes for a cut, two for a hike and the rest for no change. We see a distinct possibility, however, of a dovish swing, whereby one or both of the hawks shift their allegiance in favour of the majority. With markets not fully pricing in the first rate cut until August, this could pave the way for some weakness in sterling, as investors mull a start to easing at the bank's June meeting."

According to FXStreet cited consensus, the rate of consumer price inflation in the UK is forecast to have ebbed to 3.6% in February, from 4.0% in January.

The data is released at 0700 GMT. Before the Fed decision at 1800 GMT, Wednesday's economic calendar has a eurozone consumer confidence reading at 1500 GMT.

Against the yen, the dollar was trading at JPY150.76 at the time of the European equities close, jumping from JPY149.12.

In a long-anticipated move, the Bank of Japan on Tuesday ended its negative interest rate policy.

The Japanese central bank said it judged its monetary easing policy and yield curve control programme have "fulfilled their roles". It raised its short-term policy rate to a range of 0.0% to 0.1%, from minus 0.1% previously. The move marks the BoJ's first interest rate hike in 17 years.

XTB analyst Kathleen Brooks commented: "Right now, the market thinks that it could be one and done for the BoJ, however, with such large increases in wages, the BoJ could be forced into hiking again."

In the FTSE 100, Unilever rose 3.1%, after it said it plans to spin off its ice cream business and cut 7,500 jobs as it picks up the pace of its reorganisation plans.

The owner of Marmite, Dove soaps and Domestos announced the move alongside proposals to accelerate its "growth action plan".

Unilever intends to launch a comprehensive productivity programme which it anticipated will deliver total cost savings of around EUR800 million over the next three years, more than offsetting estimated operational dis-synergies from spinning off the ice cream business.

The changes are expected to impact around 7,500 jobs, with total restructuring costs now anticipated to be around 1.2% of group turnover for the next three years, up from around 1% of turnover previously guided.

Unilever, which owns five of the top 10 selling global ice cream brands including Wall's, Magnum and Ben & Jerry's, said the separation of ice cream will assist in the implementation of the GAP.

PureTech jumped 8.1%.

The Boston, Massachusetts-based biotherapeutics company said it plans to return USD100 million to shareholders with a tender offer, starting after it publishes its annual report in April.

Crest Nicholson slumped 9.1%, after it warned it could face a GBP15 million charge after uncovering defects in some legacy projects.

The Surrey, England-based housebuilder said the issues related to four sites that were completed prior to 2019 when the group closed its regeneration and London divisions.

Crest Nicholson said these sites will require remediation over the next three years at an estimated cost of up to GBP15 million.

Sofa retailer DFS fell 6.0%. It said pretax profit fell to GBP900,000 in the 26 weeks that ended December 24 from GBP6.8 million a year before, as revenue declined by 7.2% to GBP505.1 million from GBPP544.5 million.

In response, DFS cut its interim dividend by 27% to 1.1p from 1.5p.

Looking ahead, it lowered its financial 2024 adjusted pretax profit guidance to between GBP20 million and GBP25 million, which would be down from GBP30.6 million in financial 2023.

Revenue is expected to be between GBP1.00 billion and GBP1.02 billion, which would be down from GBP1.09 billion.

"After a solid start to January, market demand has weakened significantly over the last two months," DFS said, noting order volumes are down 16% on a year before.

Brent oil was quoted at USD87.19 a barrel late in London on Tuesday, up from USD86.27 late Monday. Gold fetched at USD2,155.26 an ounce on Tuesday, lower against USD2,158.93 late Monday.

Oil majors Shell and BP, among the FTSE 100's largest constituents, rose 1.3% and 1.0%. Conversely, gold miner Fresnillo fell 3.5%.

ActivTrades analyst Ricardo Evangelista commented: "The retreat in the precious metal's value is tied to the strengthening of the US dollar. This morning, the greenback reached a multi-week peak, signalling market anticipation of a hawkish stance from the Federal Reserve, potentially bolstering the dollar's standing. As the US central bank concludes its March meeting tomorrow, traders anticipate interest rates will remain unchanged. Nevertheless, persistent inflation and the robustness of the US economy suggest that the Fed may uphold its tight monetary policy for an extended period. In this context, the dollar's risk remains skewed to the upside, limiting the potential for gold price appreciation."

Wednesday's UK corporate calendar has annual results from insurer Prudential and a trading statement from financial services firm Investec.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
27 Feb 2024 11:28

PureTech notes positive results from Shionogi's EndeavorRx ADHD trial

(Alliance News) - PureTech Health PLC on Tuesday noted that its founded entity, Akili Inc, has announced positive results from a phase 3 clinical trial of EndeavorRx for children with attention deficit hyperactivity disorder in Japan.

Read more
20 Dec 2023 09:53

PureTech makes strong progress, expects "multiple catalysts" next year

(Alliance News) - PureTech Health PLC on Wednesday said it made "strong strategic and clinical progress" in 2023, and predicted "a productive and exciting" tear to come.

Read more
1 Dec 2023 14:29

TRADING UPDATES: N4 launches investor hub; Capricorn production falls

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday, Thursday and Friday and not separately reported by Alliance News:

Read more
17 Nov 2023 09:44

IN BRIEF: PureTech hails schizophrenia trial results for Karuna drug

PureTech Health PLC - Boston, Massachusetts-based FTSE 250 biotechnology company - Founded entity Karuna Therapeutics reports "positive results" from Phase 1b trial evaluating the effects of xanomeline-trospium, brand name KarXT, on 24-hour ambulatory blood pressure in adults with schizophrenia. Karuna says KarXT does not cause clinically meaningful blood pressure increases, with an average change from baseline at week eight of minus 0.59 mmHg or millimetre of mercury. Other vital signs like average diastolic blood pressure and heart rate were consistent with previous KarXT trials in schizophrenia. Adds that KarXT was generally well-tolerated, and side effects remained consistent with prior trials under the Emergent programme. Karuna in late September announced its application to the US Food & Drug Administration for approval of KarXT to treat schizophrenia; if successful, it will be PureTech's third therapeutic candidate to gain FDA approval. KarXT is also in development to treat psychosis associated with Alzheimer's disease.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
14 Nov 2023 10:59

PureTech Health celebrates positive results in Phase 2 anxiety trial

(Alliance News) - PureTech Health PLC on Tuesday said its therapeutic LYT-300 achieved its primary endpoint for acute anxiety reduction, in a Phase 2a trial using healthy volunteers.

Read more
11 Oct 2023 14:22

IN BRIEF: PureTech's LYT-100 shows 50% improvement to key adverse events

PureTech Health PLC - Boston-based biotechnology company - Says LYT-100 trial shows around 50% improvement in gastrointestinal and central nervous system related adverse events in adults suffering from idiopathic pulmonary fibrosis compared to US Food & Drug Administration-approved pirfenidone. Adds data shows higher dose of LYT-100 well-tolerated with no additional incidence of GI or CNS AEs when titrated up from 550 milligrams dosage.

Read more
4 Oct 2023 13:55

PureTech Health subsidiary receives fast track designation for VE202

(Alliance News) - PureTech Health PLC on Wednesday said its subsidiary Vedanta Biosciences has received fast-track designation for its VE202 treatment.

Read more
28 Sep 2023 15:08

TRADING UPDATES: Rockhopper loss widens; Synectics inks new contract

(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
27 Sep 2023 10:40

Arix Bioscience boosts net value, CEO jumping ship for PureTech Health

(Alliance News) - Arix Bioscience PLC on Wednesday said net asset value increased in its latest half year, but has since launched a strategic review due to "unfavourable" conditions while Chief Executive Officer Robert Lyne prepares to step down.

Read more
29 Aug 2023 09:39

PureTech narrows interim loss despite "stormy market challenges"

(Alliance News) - PureTech Health PLC on Tuesday said its half-year loss narrowed, but saw its revenue fall by more than half.

Read more
29 Aug 2023 09:03

LONDON MARKET OPEN: FTSE 100 catches up with bank holiday rally

(Alliance News) - Stock prices in London opened higher on Tuesday, as UK markets return from a long bank holiday weekend and news that UK shop price inflation decelerated in August.

Read more
29 Aug 2023 07:49

LONDON BRIEFING: Bunzl profit up; Rio Tinto sells copper project stake

(Alliance News) - Stocks in London are called to open higher on Tuesday, following a long bank holiday weekend.

Read more
22 Aug 2023 15:46

UK earnings, trading statements calendar - next 7 days

Wednesday 23 August 
Angling Direct PLCTrading Statement
Costain Group PLCHalf Year Results
Thursday 24 August 
Benchmark Holdings PLCQ3 Results
CRH PLCHalf Year Results
Harbour Energy PLCHalf Year Results
Hays PLCFull Year Results
Hunting PLCHalf Year Results
James Cropper PLCHalf Year Results
Macfarlane Group PLCHalf Year Results
Princess Private Equity Holding LtdHalf Year Results
Redcentric PLCFull Year Results
South32 LtdFull Year Results
Tribal Group PLCHalf Year Results
Friday 25 August 
no events scheduled 
Monday 28 August 
no events scheduled 
Tuesday 29 August 
Amaroq Minerals LtdHalf Year Results
Bunzl PLCHalf Year Results
Dalata Hotel Group PLCHalf Year Results
Faron Pharmaceuticals LtdHalf Year Results
PureTech Health PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
1 Aug 2023 17:31

TRADING UPDATES: Plant Health in Poland boost; PureTech gets US grant

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.